Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;11(1):55-59.
doi: 10.2991/jegh.k.200823.001. Epub 2020 Aug 28.

Epidemic Landscape and Forecasting of SARS-CoV-2 in India

Affiliations

Epidemic Landscape and Forecasting of SARS-CoV-2 in India

Aravind Lathika Rajendrakumar et al. J Epidemiol Glob Health. 2021 Mar.

Abstract

Background: India was one of the countries to institute strict measures for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) control in the early phase. Since, then, the epidemic growth trajectory was slow before registering an explosion of cases due to local cluster transmissions.

Methods: We estimated the growth rate and doubling time of SARS-CoV-2 for India and high burden states using crowdsourced time series data. Further, we also estimated the Basic Reproductive Number (R0) and Time-dependent Reproductive number (Rt) using serial intervals from the data. We compared the R0 estimated from five different methods and R0 from SB was further used in the analysis. We modified standard Susceptible-Infectious-Recovered (SIR) models to SIR/Death (SIRD) model to accommodate deaths using R0 with the sequential Bayesian method for simulation in SIRD models.

Results: On average, 2.8 individuals were infected by an index case. The mean serial interval was 3.9 days. The R0 estimated from different methods ranged from 1.43 to 1.85. The mean time to recovery was 14 ± 5.3 days. The daily epidemic growth rate of India was 0.16 [95% CI; 0.14, 0.17] with a doubling time of 4.30 days [95% CI; 3.96, 4.70]. From the SIRD model, it can be deduced that the peak of SARS-CoV-2 in India will be around mid-July to early August 2020 with around 12.5% of the population likely to be infected at the peak time.

Conclusion: The pattern of spread of SARS-CoV-2 in India is suggestive of community transmission. There is a need to increase funds for infectious disease research and epidemiologic studies. All the current gains may be reversed if air travel and social mixing resume rapidly. For the time being, these must be resumed only in a phased manner and should be back to normal levels only after we are prepared to deal with the disease with efficient tools like vaccines or medicine.

Question: What are the estimates of infectious disease parameters of early phase of novel SARS-CoV-2 epidemic in India?

Findings: Incidence pattern SARS-CoV-2 shows possible evidence of community transmission. However, the estimated Basic Reproductive Number (R0) is relatively lower than those observed in high burden regions (range 1.43-1.85). Our simulation using susceptible-infectious-recovered/death model shows that peak of SARS-CoV-2 in India is farther than currently projected and is likely to affect around 12.5% of population.

Meaning: The lower estimated R0 is indicative of the effectiveness of early social distancing measures and lockdown. Premature relaxation of the current control measures may result in large numbers of cases in India.

Keywords: COVID-19; India; R0; Rt.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflicts of interest.

Figures

Figure 1
Figure 1
Daily and cumulative incidence of SARS-CoV-2 cases in India (as on 12 April 2020).
Figure 2
Figure 2
Number of secondary cases resulting from contact with each index case.
Figure 3
Figure 3
Basic reproductive number (R0) calculated from different estimation methods.
Figure 4
Figure 4
SIRD models based on R0 derived from Sequential Bayesian (SB) method.

Similar articles

Cited by

References

    1. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China — key questions for impact assessment. N Engl J Med. 2020;382:692–4. doi: 10.1056/NEJMp2000929. - DOI - PubMed
    1. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–8. doi: 10.1016/j.jare.2020.03.005. - DOI - PMC - PubMed
    1. Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019‐nCoV in Italy: Where they come from? J Med Virol. 2020;92:518–21. doi: 10.1002/jmv.25699. - DOI - PMC - PubMed
    1. Arima Y, Shimada T, Suzuki M, Suzuki T, Kobayashi Y, Tsuchihashi Y, et al. Severe acute respiratory syndrome coronavirus 2 infection among returnees to Japan from Wuhan, China, 2020. Emerg Infect Dis. 2020;26:1596–600. doi: 10.3201/eid2607.200994. - DOI - PMC - PubMed
    1. Worldometer . Worldometer; 2020. Coronavirus cases [Internet] pp. 1–22. Available from: https://www.worldometers.info/coronavirus/coronavirus-cases/#daily-cases [cited April 10, 2020].

MeSH terms